Adjuvanted recombinant zoster vaccine decreases herpes zoster-associated pain and the use of pain medication across 3 randomized, placebo-controlled trials-Reference-Cited by-同舟云学术

Adjuvanted recombinant zoster vaccine decreases herpes zoster-associated pain and the use of pain medication across 3 randomized, placebo-controlled trials

Published:2022-08-19 Issue:4 Volume:164 Page:741-748
ISSN:0304-3959
Container-title:Pain
language:en
Short-container-title:PAIN

Author:

Kim Joon Hyung,Johnson Robert,Kovac Martina,Cunningham Anthony L.,Amakrane Mohamed,Sullivan Keith M.,Dagnew Alemnew F.,Curran Desmond,Schuind Anne

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Anesthesiology and Pain Medicine,Neurology (clinical),Neurology

Reference30 articles.

1. Effect of recombinant zoster vaccine on incidence of herpes zoster after autologous stem cell transplantation: a randomized clinical trial;Bastidas;JAMA,2019

2. Patient report of herpes zoster pain: incremental benefits of zoster vaccine live;Bruxvoort;Vaccine,2019

3. Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: adaptation of the brief pain inventory;Coplan;J Pain,2004

4. Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older;Cunningham;N Engl J Med,2016

5. Recombinant zoster vaccine significantly reduces the impact on quality of life caused by herpes zoster in adult autologous hematopoietic stem cell transplant recipients: a randomized placebo-controlled trial (ZOE-HSCT);Curran;Biol Blood Marrow Transpl,2019

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Link between Varicella-Zoster Virus, Autoimmune Diseases, and the Role of Recombinant Zoster Vaccine;Biomolecules;2024-06-22

2. Updated Public Health Impact and Cost Effectiveness of Recombinant Zoster Vaccine in Canadian Adults Aged 50 Years and Older;PharmacoEconomics - Open;2024-04-11

3. Immune response to the recombinant herpes zoster vaccine in people living with HIV over 50 years of age compared to non-HIV age-/gender-matched controls (SHINGR’HIV): a multicenter, international, non-randomized clinical trial study protocol;BMC Infectious Diseases;2024-03-19

4. Immune response to the recombinant herpes zoster vaccine in people living with HIV over 50 years of age compared to non-HIV age-/gender-matched controls (SHINGR’HIV): a multicenter, international, non-randomized clinical trial study protocol;2024-02-20

5. Healthy ageing: Herpes zoster infection and the role of zoster vaccination;npj Vaccines;2023-11-28